Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros











Base de datos
Idioma
Intervalo de año de publicación
1.
Artículo en Ruso | MEDLINE | ID: mdl-20734723

RESUMEN

AIM: To create and test the complex of polymerase chain reaction-based methods for detection of pathogens vectored by ticks in clinical and environmental samples. MATERIALS AND METHODS: Real time PCR methods with hybridization-fluorescent detection were developed for detection of tick-borne encephalitis virus, Borrelia burgdorferi sensu lato, Anaplasma phagocytophillum, Erlichia muris/E. chaffeensis, and B. miyamotoi. First four methods were combined in one assay in multiprime format. Efficacy of the assay was assessed by testing of blood samples from patients with tickborreliosis (166 patients), tick-born encephalitis (22 patients) and mixed infection tick-borne encephalitis + borreliosis (21 patients) from Sverdlovsk region. RESULTS: It was shown that using PCR-based assay for testing the blood samples obtained during admission, it was possible to determine the etiology of disease in 39% of patients, whereas on the basis of serological data diagnosis, as a rule, is made not earlier than on 2nd week of therapy. False-positive results of PCR diagnostics were not observed. Infections caused by Anaplasma or Erlichia were not observed. It was shown that > 50% of cases of tick borreliosis without erythema were caused by B. miyamotoi, whereas B. burgdorferi sensu lato predominated as a causative agent of erythemic form of borreliosis. CONCLUSION: Proposed complex of methods is useful for rapid diagnostics of tick-borne infections including previously unknown infection caused by B. miyamotoi.


Asunto(s)
Reacción en Cadena de la Polimerasa/métodos , Enfermedades por Picaduras de Garrapatas/diagnóstico , Anaplasma phagocytophilum/genética , Anaplasma phagocytophilum/aislamiento & purificación , Animales , Proteínas de la Membrana Bacteriana Externa/genética , Borrelia/genética , Borrelia/aislamiento & purificación , Proteínas de la Cápside/genética , Diagnóstico Diferencial , Ehrlichia/genética , Ehrlichia/aislamiento & purificación , Ehrlichiosis/diagnóstico , Virus de la Encefalitis Transmitidos por Garrapatas/genética , Virus de la Encefalitis Transmitidos por Garrapatas/aislamiento & purificación , Encefalitis Transmitida por Garrapatas/diagnóstico , Humanos , Ixodes/microbiología , Ixodes/virología , Enfermedad de Lyme/diagnóstico , ARN Bacteriano/genética , ARN Ribosómico 16S/genética , Sensibilidad y Especificidad
2.
Artículo en Ruso | MEDLINE | ID: mdl-10808573

RESUMEN

Certain specific features of the present epidemic situation with hepatitis B (HB) in Russia were established: significant growth of HB morbidity, starting from 1995; the prevalence of persons aged 15-29 years among HB patients, which was linked with the sharp activation of the sexual route of the transmission of HB virus in recent years; an essential increase in the number of patients having contacted this virus in the process of the intravenous use of drugs. The results of the use of vaccine "Engerix B" among persons belonging to different risk groups were considered (a decrease in HB morbidity among them by 8-19 times was noted), the study demonstrated high immunogenicity anti-HBs antibodies on protective titers were determined in 92.3-95.7% of the vaccinees) and low reactogenicity of the vaccine, as well as stable postvaccinal immunity (5 years after the course of vaccination was completed anti-HBs antibodies were retained in 70.6-74% of the vaccinees). The study showed that only the vaccination of adolescents in combination, in the presence of opportunity, with the immunization of newborn infants and young children in the first year of their life made it possible to produce an essential effect on the activity of the epidemic process. Already in 2 years such organization of work on the prophylaxis of HB in one of the cities of the Sverdlovsk region led to a decrease in HB morbidity by 2.9 times, and among adolescents 9 times.


Asunto(s)
Vacunas contra Hepatitis B/inmunología , Hepatitis B/prevención & control , Vacunas Sintéticas/inmunología , Enfermedad Aguda , Adolescente , Adulto , Brotes de Enfermedades/prevención & control , Brotes de Enfermedades/estadística & datos numéricos , Femenino , Hepatitis B/epidemiología , Hepatitis B/transmisión , Humanos , Lactante , Recién Nacido , Masculino , Factores de Riesgo , Federación de Rusia/epidemiología , Vacunación/estadística & datos numéricos , Vacunación/tendencias
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA